Growth Metrics

Neogenomics (NEO) Current Leases: 2009-2025

Historic Current Leases for Neogenomics (NEO) over the last 15 years, with Sep 2025 value amounting to $4.5 million.

  • Neogenomics' Current Leases rose 21.29% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year increase of 21.29%. This contributed to the annual value of $3.4 million for FY2024, which is 39.73% down from last year.
  • According to the latest figures from Q3 2025, Neogenomics' Current Leases is $4.5 million, which was up 11.23% from $4.1 million recorded in Q2 2025.
  • Neogenomics' 5-year Current Leases high stood at $7.4 million for Q2 2023, and its period low was $3.1 million during Q1 2025.
  • For the 3-year period, Neogenomics' Current Leases averaged around $4.8 million, with its median value being $4.5 million (2024).
  • Per our database at Business Quant, Neogenomics' Current Leases skyrocketed by 48.65% in 2021 and then slumped by 51.40% in 2024.
  • Neogenomics' Current Leases (Quarterly) stood at $6.9 million in 2021, then fell by 4.36% to $6.6 million in 2022, then decreased by 14.79% to $5.6 million in 2023, then slumped by 39.73% to $3.4 million in 2024, then climbed by 21.29% to $4.5 million in 2025.
  • Its Current Leases was $4.5 million in Q3 2025, compared to $4.1 million in Q2 2025 and $3.1 million in Q1 2025.